304 related articles for article (PubMed ID: 26924403)
1. A new focus of cutaneous leishmaniasis in Jammu division of Jammu and Kashmir State, India.
Kaul N; Gupta V; Bhardwaj S; Dogra D; Dogra N
Indian J Dermatol Venereol Leprol; 2016; 82(2):145-50. PubMed ID: 26924403
[TBL] [Abstract][Full Text] [Related]
2. Clinical and epidemiological study of cutaneous leishmaniasis in two tertiary care hospitals of Jammu and Kashmir: An emerging disease in North India.
Rather S; Wani M; Shah FY; Bashir S; Yaseen A; Giri FA; Sharma R; Zeerak S; Jabeen Y; Hassan I; Dogra D; Rishi R
Int J Infect Dis; 2021 Feb; 103():138-145. PubMed ID: 33181331
[TBL] [Abstract][Full Text] [Related]
3. Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in himachal pradesh, India.
Sharma NL; Mahajan VK; Kanga A; Sood A; Katoch VM; Mauricio I; Singh CD; Parwan UC; Sharma VK; Sharma RC
Am J Trop Med Hyg; 2005 Jun; 72(6):819-24. PubMed ID: 15964970
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India.
Bumb RA; Mehta RD; Ghiya BC; Jakhar R; Prasad N; Soni P; Lezama-Davila C; Satoskar AR
Br J Dermatol; 2010 Oct; 163(4):854-8. PubMed ID: 20500797
[TBL] [Abstract][Full Text] [Related]
5. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
El-Sayed M; Anwar AE
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Cutaneous Leishmaniasis: A Clinico-Epidemiological Study from North India.
Rather S; Yaseen A; Shah FY; Wani M; Krishan K; Zirak S; Sharma R; Hassan I; Dogra D; Rishi R
Indian Dermatol Online J; 2021; 12(6):852-859. PubMed ID: 34934721
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis.
Ranawaka RR; Weerakoon HS; de Silva SH
Int J Dermatol; 2015; 54(5):555-63. PubMed ID: 25600472
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of a new focus of localized cutaneous leishmaniasis in Himachal Pradesh.
Sharma NL; Mahajan VK; Negi AK
J Commun Dis; 2005 Dec; 37(4):275-9. PubMed ID: 17278657
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of single-dose radiofrequency-induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India.
Bumb RA; Prasad N; Khandelwal K; Aara N; Mehta RD; Ghiya BC; Salotra P; Wei L; Peters S; Satoskar AR
Br J Dermatol; 2013 May; 168(5):1114-9. PubMed ID: 23298394
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani.
Ranawaka RR; Weerakoon HS
J Dermatolog Treat; 2010 Sep; 21(5):286-93. PubMed ID: 20438389
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Effect Of Oral Allopurinol And Intralesional Sodium Stibogluconate In The Treatment Of Cutaneous Leishmaniasis.
Rashid HU; Ullah I; Adeeb H; Zeb M; Mohammad A; Rehman N
J Ayub Med Coll Abbottabad; 2020; 32(4):558-561. PubMed ID: 33225663
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate.
Tallab TM; Bahamdam KA; Mirdad S; Johargi H; Mourad MM; Ibrahim K; el Sherbini AH; Karkashan E; Khare AK; Jamal A
Int J Dermatol; 1996 Aug; 35(8):594-7. PubMed ID: 8854166
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
[TBL] [Abstract][Full Text] [Related]
14. Clinco-epidemiologic study of cutaneous leishmaniasis in Bikaner, Rajasthan, India.
Aara N; Khandelwal K; Bumb RA; Mehta RD; Ghiya BC; Jakhar R; Dodd C; Salotra P; Satoskar AR
Am J Trop Med Hyg; 2013 Jul; 89(1):111-5. PubMed ID: 23716414
[TBL] [Abstract][Full Text] [Related]
15. A new focus of cutaneous leishmaniasis in Himachal Pradesh (India).
Sharma RC; Mahajan VK; Sharma NL; Sharma A
Indian J Dermatol Venereol Leprol; 2003; 69(2):170-2. PubMed ID: 17642870
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
Asilian A; Sadeghinia A; Faghihi G; Momeni A; Amini Harandi A
Ann Trop Med Parasitol; 2003 Jul; 97(5):493-8. PubMed ID: 12930612
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia (1956-2002).
Al-Tawfiq JA; AbuKhamsin A
Int J Infect Dis; 2004 Jul; 8(4):244-50. PubMed ID: 15234329
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous leishmaniasis: a report of two cases seen at a tertiary dermatological centre in Singapore.
Tan HH; Wong SS; Ong BH
Singapore Med J; 2000 Apr; 41(4):179-81. PubMed ID: 11063184
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey.
Uzun S; Durdu M; Culha G; Allahverdiyev AM; Memisoglu HR
J Parasitol; 2004 Aug; 90(4):853-9. PubMed ID: 15357081
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of cutaneous leishmaniasis in Fuenlabrada, Madrid.
Aguado M; Espinosa P; Romero-Maté A; Tardío JC; Córdoba S; Borbujo J
Actas Dermosifiliogr; 2013 May; 104(4):334-42. PubMed ID: 23567452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
